Unexpected platelets elevation in a patient with idiopathic thrombocytopenia treated with oseltamivir for influenza infection

Oseltamivir is a neuraminidase inhibitor approved for the prevention and treatment of influenza. Few haematological side effects have been reported with oseltamivir. We report herein the case of an unexpected platelet increase in a 46-year-old woman with idiopathic thrombocytopenia (ITP) treated wit...

Full description

Saved in:
Bibliographic Details
Published in:Fundamental & clinical pharmacology 2016, Vol.30 (5), p.483-485
Main Authors: Bigot, Pierre, Auffret, Marine, Gautier, Sophie, Weinborn, Marie, Ettahar, Nicolas-Kader, Coupé, Patrick
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Oseltamivir is a neuraminidase inhibitor approved for the prevention and treatment of influenza. Few haematological side effects have been reported with oseltamivir. We report herein the case of an unexpected platelet increase in a 46-year-old woman with idiopathic thrombocytopenia (ITP) treated with oseltamivir for influenza. The mechanism may involve the neuraminidase inhibition which decrease platelet surface sialic acid content and reduce their removal by the reticuloendothelial system. Oseltamivir may be responsible for platelet increase especially in patients with ITP.
ISSN:1472-8206
DOI:10.1111/fcp.12213